GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Net Margin %

Kyowa Kirin Co (TSE:4151) Net Margin % : 29.86% (As of Sep. 2023)


View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Kyowa Kirin Co's Net Income for the three months ended in Sep. 2023 was 円31,908 Mil. Kyowa Kirin Co's Revenue for the three months ended in Sep. 2023 was 円106,844 Mil. Therefore, Kyowa Kirin Co's net margin for the quarter that ended in Sep. 2023 was 29.86%.

The historical rank and industry rank for Kyowa Kirin Co's Net Margin % or its related term are showing as below:

TSE:4151' s Net Margin % Range Over the Past 10 Years
Min: 4.77   Med: 12.8   Max: 21.94
Current: 13.77


TSE:4151's Net Margin % is ranked better than
78.61% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs TSE:4151: 13.77

Kyowa Kirin Co Net Margin % Historical Data

The historical data trend for Kyowa Kirin Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Net Margin % Chart

Kyowa Kirin Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.04 21.94 14.77 14.86 13.45

Kyowa Kirin Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.41 3.81 13.64 8.41 29.86

Competitive Comparison of Kyowa Kirin Co's Net Margin %

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's Net Margin % falls into.



Kyowa Kirin Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Kyowa Kirin Co's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=53573/398371
=13.45 %

Kyowa Kirin Co's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=31908/106844
=29.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyowa Kirin Co  (TSE:4151) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Kyowa Kirin Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (TSE:4151) Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines